Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 1966 AL 1980

Melatonin levels in the Alzheimer's disease continuum: a systematic review

Nous A, Engelborghs S, Smolders I.

Alzheimers Res Ther. 2021 Feb 23;13(1):52. doi: 10.1186/s13195-021-00788-6.

Empirical assessment of biases in cerebrospinal fluid biomarkers of Alzheimer's disease: an umbrella review and re-analysis of data from meta-analyses

Jeong DY, Lee J, Kim JY, Lee KH, Li H, Lee JY, Jeong GH, Yoon S, Park EL, Hong SH, Kang JW, Song TJ, Leyhe T, Eisenhut M, Kronbichler A, Smith L, Solmi M, Stubbs B, Koyanagi A, Jacob L, Stickley A, Thompson T, Dragioti E, Oh H, Brunoni AR, Carvalho AF, Kim MS, Yon DK, Lee SW, Yang JM, Ghayda RA, Shin JI, Fusar-Poli P.

Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1536-1547. doi: 10.26355/eurrev_202102_24862.

Alzheimer's disease and its treatment by different approaches: A review

Srivastava S, Ahmad R, Khare SK.

Eur J Med Chem. 2021 Apr 15;216:113320. doi: 10.1016/j.ejmech.2021.113320. Epub 2021 Feb 23.

Alzheimer's Dementia: The Emerging Role of Positron Emission Tomography

Tripathi SM, Murray AD.

Neuroscientist. 2022 Oct;28(5):507-519. doi: 10.1177/1073858421997035. Epub 2021 Mar 4.

Association between CSF Aβ42 and amyloid negativity in patients with different stage mild cognitive impairment

He B, Wang L, Xu B, Zhang Y; Alzheimer’s Disease Neuroimaging Initiative.

Neurosci Lett. 2021 May 29;754:135765. doi: 10.1016/j.neulet.2021.135765. Epub 2021 Mar 2.

Imaging Techniques in Alzheimer's Disease: A Review of Applications in Early Diagnosis and Longitudinal Monitoring

van Oostveen WM, de Lange ECM.

Int J Mol Sci. 2021 Feb 20;22(4):2110. doi: 10.3390/ijms22042110.

2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework

Leuzy A, Ashton NJ, Mattsson-Carlgren N, Dodich A, Boccardi M, Corre J, Drzezga A, Nordberg A, Ossenkoppele R, Zetterberg H, Blennow K, Frisoni GB, Garibotto V, Hansson O.

Eur J Nucl Med Mol Imaging. 2021 Jul;48(7):2121-2139. doi: 10.1007/s00259-021-05258-7. Epub 2021 Mar 5.

The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers

Ashton NJ, Leuzy A, Karikari TK, Mattsson-Carlgren N, Dodich A, Boccardi M, Corre J, Drzezga A, Nordberg A, Ossenkoppele R, Zetterberg H, Blennow K, Frisoni GB, Garibotto V, Hansson O.

Eur J Nucl Med Mol Imaging. 2021 Jul;48(7):2140-2156. doi: 10.1007/s00259-021-05253-y. Epub 2021 Mar 6.

An Introduction to Ultrasensitive Assays for Plasma Tau Detection

Ding XL, Tuo QZ, Lei P.

J Alzheimers Dis. 2021;80(4):1353-1362. doi: 10.3233/JAD-201499.

Molecular imaging and fluid biomarkers of Alzheimer's disease neuropathology: an opportunity for integrated diagnostics

Garibotto V, Boccardi M, Chiti A, Frisoni GB.

Eur J Nucl Med Mol Imaging. 2021 Jul;48(7):2067-2069. doi: 10.1007/s00259-020-05116-y.

Blood tests to screen for Alzheimer's disease

Husain M.

Brain. 2021 Mar 3;144(2):355-356. doi: 10.1093/brain/awaa462.

Therapy for Alzheimer's disease: Missing targets and functional markers?

Stoiljkovic M, Horvath TL, Hajós M.

Ageing Res Rev. 2021 Jul;68:101318. doi: 10.1016/j.arr.2021.101318. Epub 2021 Mar 9.

Microglia Biomarkers in Alzheimer's Disease

Zhang PF, Hu H, Tan L, Yu JT.

Mol Neurobiol. 2021 Jul;58(7):3388-3404. doi: 10.1007/s12035-021-02348-3. Epub 2021 Mar 12.

Clinical validity of increased cortical binding of tau ligands of the THK family and PBB3 on PET as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework

Chiotis K, Dodich A, Boccardi M, Festari C, Drzezga A, Hansson O, Ossenkoppele R, Frisoni G, Garibotto V, Nordberg A.

Eur J Nucl Med Mol Imaging. 2021 Jul;48(7):2086-2096. doi: 10.1007/s00259-021-05277-4. Epub 2021 Mar 15.

Spatial correlation maps of the hippocampus with cerebrospinal fluid biomarkers and cognition in Alzheimer's disease: A longitudinal study

Liu G, Liu C, Qiu A; Alzheimer's Disease Neuroimaging Initiative.

Hum Brain Mapp. 2021 Jun 15;42(9):2931-2940. doi: 10.1002/hbm.25414. Epub 2021 Mar 19.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias